Table 1.
Overview of ablation sessions
| Date | Nr. ablated lesions | Max. diameter (mm) | Nr. of coaxial needles | Classification | Liver segment | Location | Time of ablation (min) | Complication | Length of hospital stay (days) | Treatment of complication | Additional therapy |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02.05.07 | 1 | 100 | 18 | Initial | I, V, VI, VII, VIII | Vessel, bile duct, subphrenic | 300 | Post-ablation syndrome | 21 | – | |
| 13.06.07 | 2 | 40/12 | 6/1 | Initial/residual | VII/V | Subcapsular/VCI | 44 | Pleural effusion | 6 | Conservative | |
| 09.07.09 | 2 | 10/5 | 2/1 | New/new | IVb/VIII,IVa | Subcapsular/subcapsular | 36 | None | 3 | – | Ablation of lower mediastinal lymph node (1 needle) |
| 07.12.12 | 1 | 45 | 9 | Recurrence | V | Central | 44 | None | 4 | – | |
| 22.05.13 | 1 | 10 | 2 | New | IVb | Subcapsular | 6 | None | 3 | – | |
| 27.02.15 | 2 (1) | 28/28 | 2/3 | Recurrence/recurrence | IVa/V,VIII | Subphrenic/gallbladder | 20 | Pleural effusion | 15 | Drainage | SIRE of 1.5 cm recurrence with direct proximity to left portal vein and bile duct |
| 21.10.15 | 2 | 12/8 | 2/1 | New/new | II/II | Subphrenic/subcapsular | 15 | None | 3 | – | |
| 10.06.16 | 1 | 7 | 1 | New | III | – | 12 | None | 3 | – | |
| 31.01.18 | 2 | 24/23 | 2/2 | Recurrence/recurrence | VII/VII | Direct proximity V. cava inf./subcapsular | 16 | None | 9 | – | Ablation of tumor thrombus in V. cava inf. (4 × 2.5 cm; 2 needles) and intraoperative anticoagulation with 2500 IE heparin |
| 21.03.18 | 1 | 10 | 1 | Recurrence | IVa, IVb | Gallbladder bed | 5 | None | 4 | – | Ablation of residual tumor thrombus in V. cava inf. (2 cm; 1 needle) and intraoperative anticoagulation with 2500 IE heparin |